!!!Klaus Schulze-Osthoff
[{AcadMemberDataPlugin}]
\\ \\
__Present and Previous Positions__
* 2008 - present Director and Chair, Department of Molecular Medicine, University of Tübingen, Germany
* 2012 - present Appointed Research Fellow of the German Cancer Research Center, Heidelberg, Germany
* 2011 - present Elected Spokesperson of the German Consortium for Translational Cancer Research (DKTK), Partner Site Tübingen
* 2009 - 2013 Appointed Scientific Director of the Comprehensive Cancer Center, Tübingen, Germany
* 2001 - 2008 Professor and founding Director of the Institute of Molecular Medicine, University of Düsseldorf, Germany
* 1999 - 2001 Professor, Department of Immunology & Cell Biology, University of Münster, Germany
* 1997 - 1998 Professor, Department of Internal Medicine I, University of Tübingen, Germany
* 1995 - 1997 Assistant Professor and Lecturer, Institute of Biochemistry and Molecular Biology, University of Freiburg, Germany
* 1992 - 1995 Junior Research Group Leader, German Cancer Research Center (DKFZ), Heidelberg, Germany
* 1990 - 1992 Postdoctoral researcher with Prof. Walter Fiers, Laboratory of Molecular Biology, University of Ghent, Belgium
\\
__Fields of Scholarship__
[{AcadMemberFOScholarshipPlugin}]
\\
__Honours and Awards__
*Since 2021 Appointed steering committee member, National Center for Tumor Diseases (NCT SouthWest), Germany
*Since 2019 Board member, Cluster of Excellence IFIT, Tübingen, Germany
*Since 2013 Board of Trustees, Comprehensive Cancer Center Tübingen, Germany
*Since 2011 Elected spokesperson, German Consortium for Translational Cancer Research (DKTK)
* Elected member of academic bodies at Tübingen University: Faculty Council, Research Commission;  Strategy Commission 
*2016, 2005, 2002 Research Grant Award, German Cancer Aid Foundation
*2012 - 2016 Scientific Advisory Board, Comprehensive Cancer Center, Düsseldorf, Germany
*2011 - 2013 Spokesperson of the Collaborative Research Center  773 “Therapy resistance”, Tübingen 
*Since 2010 Scientific Advisory Board, Biocheck GmbH, Münster, Germany
*2010 Offer for the Directorship of the Leibniz Institute IfADo, Dortmund, Germany (call declined)
*2002 - 2007  Scientific Advisory Board VIB (Vlaams Instituut voor Biotechnologie), Ghent, Belgium
*2008 - 2012 Member of the scientific committee of the European Commission 'Emerging Newly Identified Health Risks' (SCENIHR)
*2008 German University Medical Innovation Award
*2007 Scientific Advisory Board, EU STREP Consortium GROWTHSTOP
*2006 Scientific Advisory Board of Pfizer, Groton, USA
*2000 Offer for Chair in Molecular Hepatology, University of Bonn, Germany (call declined)
*1998 Long-Term FEBS (Federation of European Biochemical Societies) Fellowship
*1997 Offer for the Chair position in Biochemistry, University of Halle, Germany (call declined)
*1995 'Skin and Environment' Award, Grünenthal AG
*1990 - 1995 Fellowship of the German Ministry of Education and Research
\\
%%columns-900

%%coolborders-140-70
[{Image src='User/paper_content_pencil_48.png' width='48px' class='image_left'}]
[Curriculum Vitae |User/Schulze-Osthoff_Klaus/CV]
%%
----
%%coolborders-140-70
[{Image src='User/book_48.png' class='image_left'}]
[Publication list|User/Schulze-Osthoff_Klaus/Publications]
%%
----
%%coolborders-140-70
[{Image src='User/camera_noflash_48.png' width='48px' class='image_left'}]
[Highlights of my work and anecdotes|User/Schulze-Osthoff_Klaus/Highlight]
%%
----
%%coolborders-140-70
[{Image src='User/database_48.png' class='image_left'}]
[Other information|User/Schulze-Osthoff_Klaus/OtherInformation]
%%
%%

[{ALLOW view All}][{ALLOW edit kschulze-osthoff}][{ALLOW upload kschulze-osthoff}][{ALLOW comment All}]



[{ALLOW view All}][{ALLOW edit kschulze-osthoff}][{ALLOW upload kschulze-osthoff}][{ALLOW comment All}]